Question 1

What is the catalog number for 2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide?

Accepted Answer

The catalog number for 2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide is PC400578.

Question 2

What sizes are available for 2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide?

Accepted Answer

2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide is available in the following size(s): 1 Each.

Question 3

Is 2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide in stock?

Accepted Answer

2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Can I get a trial-size or discounted first order of this product?

Accepted Answer

We don’t generally offer free samples, but trial discounts in exchange for feedback and validation results are almost always possible. Contact us with your intended application to arrange one.

Question 5

Do you offer bulk or custom quantities of this product?

Accepted Answer

Yes. Ordering two or more units, or combining this with other products, usually qualifies for a discount depending on quantity. Contact our sales team with your required volume for a custom quote.

Question 6

Do you provide a Certificate of Analysis (CoA) for this product?

Accepted Answer

A Certificate of Analysis is available for most products upon request. Contact our support team with the lot number to obtain the relevant CoA.

2-Hydroxy-N- (3- (trifluoromethyl) phenyl) quinoline-5-carboxamide

Product Specifications

CAS Number

MDL Number

Purity

Smiles

Frequently Asked Questions

Explore Other Products

Anti-Progesterone Receptor/PGR Antibody Picoband®, Carrier-free

Aurora B (Proliferation Marker) (AURKB/3121R), CF740 conjugate, 0.1mg/mL

NKX2.2 (NX2/294), CF568 conjugate, 0.1mg/mL

CD79b (B-Cell Marker) (IGB/1842), CF640R conjugate, 0.1mg/mL

CD31 / PECAM-1 (Endothelial Cell Marker) (PECAM1/3530), CF647 conjugate, 0.1mg/mL

PD-L1 / PDCD1LG1 / CD274 / B7-H1 (Cancer Immunotherapy Target) (PDL1/2741), CF740 conjugate, 0.1mg/mL